[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK0540580T3 - Polymert lægemiddelafgivelsessystem - Google Patents

Polymert lægemiddelafgivelsessystem

Info

Publication number
DK0540580T3
DK0540580T3 DK91913230.8T DK91913230T DK0540580T3 DK 0540580 T3 DK0540580 T3 DK 0540580T3 DK 91913230 T DK91913230 T DK 91913230T DK 0540580 T3 DK0540580 T3 DK 0540580T3
Authority
DK
Denmark
Prior art keywords
drug delivery
delivery system
polymeric drug
polyamines
polymeric
Prior art date
Application number
DK91913230.8T
Other languages
English (en)
Inventor
Samuel J Tremont
Paul Waddell Collins
Williams Eldredge Perkins
Peter Hadley Jones
Original Assignee
Monsanto Co
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co, Searle & Co filed Critical Monsanto Co
Application granted granted Critical
Publication of DK0540580T3 publication Critical patent/DK0540580T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02Polyamines
    • C08G73/0206Polyalkylene(poly)amines
    • C08G73/0213Preparatory process
    • C08G73/0226Quaternisation of polyalkylene(poly)amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02Polyamines
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S525/00Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S525/923Aminoplast having terminal ethylenic unsaturation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
DK91913230.8T 1990-07-26 1991-07-22 Polymert lægemiddelafgivelsessystem DK0540580T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55804190A 1990-07-26 1990-07-26

Publications (1)

Publication Number Publication Date
DK0540580T3 true DK0540580T3 (da) 1994-05-16

Family

ID=24227945

Family Applications (2)

Application Number Title Priority Date Filing Date
DK91915184.5T DK0540670T3 (da) 1990-07-26 1991-07-22 Fremgangsmåde til fremstilling af tværbundne polyaminer
DK91913230.8T DK0540580T3 (da) 1990-07-26 1991-07-22 Polymert lægemiddelafgivelsessystem

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK91915184.5T DK0540670T3 (da) 1990-07-26 1991-07-22 Fremgangsmåde til fremstilling af tværbundne polyaminer

Country Status (15)

Country Link
US (5) US5827925A (da)
EP (2) EP0540580B1 (da)
JP (2) JP2611073B2 (da)
AT (2) ATE135721T1 (da)
AU (2) AU8285991A (da)
CA (2) CA2086527A1 (da)
DE (2) DE69101710T2 (da)
DK (2) DK0540670T3 (da)
ES (2) ES2084825T3 (da)
GR (1) GR3019804T3 (da)
IE (1) IE912630A1 (da)
NZ (1) NZ239133A (da)
PT (1) PT98442B (da)
WO (2) WO1992001477A1 (da)
ZA (1) ZA915892B (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE135721T1 (de) * 1990-07-26 1996-04-15 Monsanto Co Verfahren zur herstellung vernetzter polyamine
JPH06239931A (ja) * 1992-12-14 1994-08-30 Monsanto Co ポリ(第2アミン)とその製造方法
US5559193A (en) * 1993-12-20 1996-09-24 Monsanto Company Controlled functional density polyamines and method for preparation thereof
US5691422A (en) * 1994-03-07 1997-11-25 Exxon Chemical Patents Inc. Saturated polyolefins having terminal aldehyde or hydroxy substituents and derivatives thereof
US5674950A (en) * 1994-03-07 1997-10-07 Exxon Chemical Patents Inc. Polymers having terminal hydroxyl aldehyde, or alkylamino substitutents and derivatives thereof
US6890524B1 (en) 1997-04-04 2005-05-10 Monsanto Company Hydrolyzable delivery system using cross-linked polymeric resins as vehicles
US6413945B1 (en) * 1997-04-04 2002-07-02 Pharmacia Corporation Gastro-specific prodrugs
US6030959A (en) * 1997-04-04 2000-02-29 Monsanto Company Gastro-specific prodrugs
WO1998044952A1 (en) * 1997-04-04 1998-10-15 Monsanto Company pH-SELECTIVE DELIVERY SYSTEM USING CROSS-LINKED POLYMERIC RESINS AS VEHICLES
WO1998044951A2 (en) * 1997-04-04 1998-10-15 Monsanto Company Hydrolysable delivery system using cross-linked polymeric resins as vehicles
CN1414902A (zh) 1999-12-28 2003-04-30 金伯利-克拉克环球有限公司 硬质表面用受控释放抗菌擦
WO2001047403A1 (en) 1999-12-28 2001-07-05 Kimberly-Clark Worldwide, Inc. Use-dependent indicator system for absorbent articles
US6315987B1 (en) * 2000-05-10 2001-11-13 Isp Investments Inc. Polymeric delivery and release systems for oral care actives
US7097181B2 (en) * 2001-11-02 2006-08-29 Outrigger, Inc. Angular handle assembly for wheeled luggage
EP1501352B1 (en) * 2001-12-14 2015-02-18 The University Of Wyoming Controlled release of oxycodone
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
RS51707B (sr) * 2002-12-12 2011-10-31 Nycomed Gmbh. Kombinacija leka sastavljena od r, r - formoterola i ciklezonida
EP1626748B1 (en) * 2003-05-13 2012-07-11 Medtronic, Inc. Moisture curable materials for delivery of agents, methods, and medical devices
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
JP5021621B2 (ja) 2005-04-13 2012-09-12 アスション ファーマ エー/エス 皮膚の結合組織病を治療するためのβ−2アドレナリン受容体作動薬
US8367096B2 (en) * 2005-07-19 2013-02-05 Boston Scientific Scimed, Inc. Polymers having covalently bound therapeutic agents
US20090317335A1 (en) * 2006-04-20 2009-12-24 Wenbin Lin Hybrid Nanomaterials as Multimodal Imaging Contrast Agents
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
MX2009001534A (es) * 2006-08-10 2009-04-08 Us Gov Health & Human Serv Preparacion de (r,r)-fenoterol y analogos de (r,r)- o (r,s)-fenoterol y su uso en el tratamiento de insuficiencia cardiaca congestiva.
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
MX2009008170A (es) * 2007-01-31 2009-08-12 Allergan Inc Nuevos biomateriales para la distribucion de farmaco ocular y metodo para hacerlos y utilizarlos.
US20110135571A1 (en) * 2008-02-22 2011-06-09 Wenbin Lin Hybrid nanoparticles as anti-cancer therapeutic agents and dual therapeutic/imaging contrast agents
US8945527B2 (en) * 2008-04-25 2015-02-03 The University Of North Carolina At Chapel Hill Degradable compounds and methods of use thereof, particularly with particle replication in non-wetting templates
US20130203675A1 (en) 2010-09-16 2013-08-08 Joseph M. DeSimone Asymmetric biofunctional silyl monomers and particles thereof as prodrugs and delivery vehicles for pharmaceutical, chemical and biological agents
EP3494974B1 (en) 2011-07-08 2023-10-18 The University of North Carolina at Chapel Hill Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
JP6590802B2 (ja) 2013-11-06 2019-10-16 ザ ユニバーシティ オブ シカゴThe University Of Chicago 化学療法用薬剤、核酸及び光増感剤の送達又は共送達のためのナノスケール輸送体
US10806694B2 (en) 2014-10-14 2020-10-20 The University Of Chicago Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof
CN110731961A (zh) 2014-10-14 2020-01-31 芝加哥大学 金属有机框架、药物制剂及其在制备药物中的用途
JP7090034B2 (ja) 2016-05-20 2022-06-23 ザ ユニバーシティ オブ シカゴ 化学療法、標的療法、光線力学療法、免疫療法及びそれらの任意の組み合わせのためのナノ粒子
EP3555280A4 (en) 2016-12-19 2020-09-09 The Regents of The University of California PEPTIDES SENSITIVE TO TWO ENZYMES
EP3554548A4 (en) 2016-12-19 2020-08-19 The Regents of The University of California NON-CRUSHABLE PILL FORMULATIONS
IL269506B2 (en) 2017-03-22 2024-04-01 Genentech Inc Hyaluronic acid cross-linked hydrogel preparations and methods
WO2019028250A1 (en) 2017-08-02 2019-02-07 The University Of Chicago NOMOGENEOUS ORGANOMETALLIC ORGANOMETRIC ORGANOMETRIC LAYERS FOR X-RAY INDUCED PHOTODYNAMIC THERAPY, RADIOTHERAPY, RODIODYNAMIC THERAPY, CHEMOTHERAPY, IMMUNOTHERAPY, AND ANY COMBINATION THEREOF
CA3030416A1 (en) 2018-01-18 2019-07-18 Research Triangle Institute Polyamine phosphorus dendrimer materials for carbon dioxide capture

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2923662A (en) * 1957-07-11 1960-02-02 White Lab Inc Appetite depressant resin
US3383426A (en) * 1963-09-09 1968-05-14 Exxon Research Engineering Co Hydroformylation process for polymers
DE2060703A1 (de) * 1970-12-10 1972-06-22 Hoechst Ag Glasklare Polyamide
FR2273554A1 (fr) * 1974-06-04 1976-01-02 Wellcome Found Derives de prostaglandines et medicaments contenant ces substances
IT1044797B (it) * 1974-10-15 1980-04-21 Ferruti Paolo Alti polimeri contenenti radicali prostaglandinici processo per la loro preparazione e loro impiego
US4068056A (en) * 1975-03-05 1978-01-10 Exxon Research And Engineering Company Aminated polymeric additives for fuel and lubricants
US4292242A (en) * 1978-12-06 1981-09-29 Sri International Production of amines
US4356166A (en) * 1978-12-08 1982-10-26 University Of Utah Time-release chemical delivery system
JPH0323530B2 (da) * 1979-03-21 1991-03-29 Nat Res Dev
US4296004A (en) * 1979-09-10 1981-10-20 Henkel Corporation Polycyclic polyamines
US4297481A (en) * 1980-02-22 1981-10-27 W. R. Grace & Co. Process of forming polymeric polyamine/amide
US4312965A (en) * 1980-02-22 1982-01-26 W. R. Grace & Co. Process for forming amine/amide containing polymers
US4489056A (en) * 1982-06-30 1984-12-18 Merck & Co., Inc. Acid anhydrides as rate controlling agent for the erosion of polymers which latter polymers have beneficial substances dispersed throughout their matrix or where the polymer matrix surrounds the beneficial substance
US4675182A (en) * 1983-02-12 1987-06-23 Bayer Aktiengesellschaft Complexes of prostaglandins
US4526936A (en) * 1983-03-18 1985-07-02 W. R. Grace & Co. Process for the preparation of polymeric amine containing products
US4558101A (en) * 1983-03-18 1985-12-10 W. R. Grace & Co. Process for the preparation of polymeric amine containing products
US4606939A (en) * 1983-06-22 1986-08-19 The Ohio State University Research Foundation Small particle formation
US4608278A (en) * 1983-06-22 1986-08-26 The Ohio State University Research Foundation Small particule formation and encapsulation
US4459310A (en) * 1983-06-27 1984-07-10 G.D. Searle & Co. Method for cholesterol lowering
US4543411A (en) * 1983-11-10 1985-09-24 Texaco Inc. Process for selective preparation of secondary and tertiary amines
US4503217A (en) * 1983-11-10 1985-03-05 Texaco Inc. Process for selective preparation of polymeric polyamines
US4795436A (en) * 1983-11-14 1989-01-03 Bio-Mimetics, Inc. Bioadhesive composition and method of treatment therewith
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
US4600578A (en) * 1984-05-11 1986-07-15 Bristol-Myers Company Method of inhibiting diarrhea
US4639366A (en) * 1984-06-06 1987-01-27 Merck & Co., Inc. Polymers containing pendant acid functionalities and labile backbone bonds
US4765973A (en) * 1984-06-06 1988-08-23 Merck & Co., Inc. Polymers containing pendant acid functionalities and labile backbone bonds
US4794199A (en) * 1984-07-05 1988-12-27 Texaco Inc. Process for synthesis of primary amines from olefins, syngas and ammonia
US4663308A (en) * 1984-07-18 1987-05-05 Medical College Of Ohio Method of use of polymers containing cross-linked azo bonds for releasing therapeutic agents into the lower gastrointestinal tract
DE3686275T2 (de) * 1985-01-11 1993-03-18 Teijin Ltd Praeparate mit verzoegerter freisetzung.
US4548955A (en) * 1985-02-25 1985-10-22 Sogo Pharmaceutical Company Limited Nylon capsule responding to pH
US4780319A (en) * 1985-07-08 1988-10-25 Merck & Co., Inc. Organic acids as catalysts for the erosion of polymers
US4657984A (en) * 1985-10-16 1987-04-14 Texaco Inc. Process for formation of dialkylaminomethylated internal olefin polymers
US4847250A (en) * 1985-11-29 1989-07-11 Merck & Co., Inc. Pyroglutamic acid esters used as dermal penetration enhancers for drugs
US4764364A (en) * 1986-02-25 1988-08-16 S R I International Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product
US4705898A (en) * 1986-04-04 1987-11-10 Texaco Inc. Preparation of disecondary amines from diolefins and primary amines
US4894226A (en) * 1986-11-14 1990-01-16 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polyproline conjugation
IL83715A0 (en) * 1987-08-31 1988-01-31 Yeda Res & Dev Pharmaceutical anti-protozoal compositions
ATE96030T1 (de) * 1988-03-24 1993-11-15 Taisho Pharmaceutical Co Ltd Cholesterolvermindernde wirkstoffe.
GB8912903D0 (en) * 1989-06-05 1989-07-26 Smith Kline French Lab Compounds
GB8913699D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
DE3930696A1 (de) * 1989-09-14 1991-03-28 Hoechst Ag Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel
CA2042603A1 (en) * 1989-10-02 1991-04-03 David Coates Electrooptical liquid crystal system
GB8928278D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
US5049625A (en) * 1990-03-08 1991-09-17 The Goodyear Tire & Rubber Company Polymeric diphenyldiamines
CA2040996A1 (en) * 1990-05-02 1991-11-03 Robert L. Albright Composition and method for controlling cholesterol
GB9010784D0 (en) * 1990-05-14 1990-07-04 Shell Int Research Process for the preparation of a secondary amine
ATE135721T1 (de) * 1990-07-26 1996-04-15 Monsanto Co Verfahren zur herstellung vernetzter polyamine
US5134200A (en) * 1990-10-09 1992-07-28 The Goodyear Tire & Rubber Company Polymers containing chemically bound amine antidegradants
EP0534316A1 (de) * 1991-09-21 1993-03-31 Hoechst Aktiengesellschaft Verwendung von alkylierten Polyethyleniminderivaten zur Anreicherung von Gallensäuren
EP0548793A3 (en) * 1991-12-20 1995-11-02 Hoechst Ag Ethylenic-unsaturated bile acid derivatives, process for their production and preliminary processes therefor
JPH06239931A (ja) * 1992-12-14 1994-08-30 Monsanto Co ポリ(第2アミン)とその製造方法

Also Published As

Publication number Publication date
US5676939A (en) 1997-10-14
CA2085366A1 (en) 1992-01-27
EP0540580A1 (en) 1993-05-12
DE69118188D1 (de) 1996-04-25
EP0540670A1 (en) 1993-05-12
NZ239133A (en) 1993-10-26
CA2085366C (en) 2001-06-12
EP0540670B1 (en) 1996-03-20
DE69101710D1 (de) 1994-05-19
ES2084825T3 (es) 1996-05-16
ZA915892B (en) 1992-09-30
ATE135721T1 (de) 1996-04-15
DK0540670T3 (da) 1996-04-29
US5474767A (en) 1995-12-12
WO1992001477A1 (en) 1992-02-06
JP2611073B2 (ja) 1997-05-21
DE69118188T2 (de) 1996-10-31
JPH05508680A (ja) 1993-12-02
EP0540580B1 (en) 1994-04-13
JPH06502391A (ja) 1994-03-17
AU8285991A (en) 1992-02-18
WO1992001730A1 (en) 1992-02-06
IE912630A1 (en) 1992-01-29
GR3019804T3 (en) 1996-07-31
ES2053333T3 (es) 1994-07-16
US5827925A (en) 1998-10-27
PT98442A (pt) 1992-06-30
ATE104154T1 (de) 1994-04-15
DE69101710T2 (de) 1994-08-18
AU8418891A (en) 1992-02-18
US5795567A (en) 1998-08-18
CA2086527A1 (en) 1992-01-27
US5693319A (en) 1997-12-02
PT98442B (pt) 1999-01-29

Similar Documents

Publication Publication Date Title
DK0540580T3 (da) Polymert lægemiddelafgivelsessystem
ATE52027T1 (de) Formulierungen mit verzoegerter freisetzung.
IT8620010A0 (it) Copolimeri solubili e biodegradabili per legare sostanze biologicamente attive.
EP0674528A4 (en) DRUG DELIVERY SYSTEM BASED ON CYCLODEXTRIN AND A POLYMER.
FR2712030B1 (fr) Système d'injection et éléments d'injection tricoaxiaux associés.
DE69128386D1 (de) Verteiltes Nachrichtensystem und -verfahren
TR199700845T1 (xx) Aerojel'lerin tar�mda kullan�lmas�.
ATE89485T1 (de) Neurologisches therapiesystem.
DZ1488A1 (fr) Système et procédé d'irrigation.
BR9005132A (pt) Sistema de conexao submarina e conector ativo utilizado no referido sistema
IT9047729A0 (it) Dispositivo per l'introduzione sub-cutanea, in particolare adatto per impiantare capelli artificiali.
DE69105503D1 (de) Lagerungs und Rückholsystem.
DE69109885D1 (de) Phosphatgruppen enthaltende Pfropfpolymere und Verwendung.
NO910787D0 (no) Tredimensjonalt celle- og vevskultursystem.
GB9016071D0 (en) Molecular complexes and their uses in biological systems
Allan Wildlife Census on Rocky Mountain Bighorn Sheep (Ovis canadensis canadensis) in Jasper National Park
Frowein Male Captus, Male Detentus: A Human Right
Bosselmann South Lake District Plan
IT220280Z2 (it) Morsetto di supporto perfezionato, in particolare per impianti di ditribuzione idrica in allevamenti avicoli e simili
GB9115270D0 (en) Molecular complexes and their uses in biological systems
NO910943D0 (no) Delbart roer- og roerkapslingssystem.
NO901318D0 (no) Delbart roer- og roerkapslingssystem.
IT9035629U1 (it) Dispositivo per l'introduzione sub-cutanea, in particolare adatto per impiantare capelli artificiali.
PH31166A (en) Polymeric drug delivery system.
ES1010911Y (es) Modulo de distribucion y entrega.